Kinetics of the natural, humoral immune response to Salmonella enterica serovar Typhi in Kathmandu, Nepal

Clinical and Vaccine Immunology

Volumn 16, Issue 10, 2009, Pages 1413-1419

  Pulickal, Anoop S ^a   Gautam, Samir ^b   Clutterbuck, Elizabeth A ^a   Thorson, Stephen ^b   Basynat, Buddha ^b   Adhikari, Neelam ^b   Makepeace, Katherine ^c   Rijpkema, Sjoerd ^d   Borrow, Ray ^e   Farrar, Jeremy J ^f   Pollard, Andrew J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b PATAN HOSPITAL   (Nepal)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^e PUBLIC HEALTH ENGLAND   (United Kingdom)

^f OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; TYPHOID VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERICIDAL ACTIVITY; CHILD; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENDEMIC DISEASE; HUMAN; HUMORAL IMMUNITY; INFANT; INNATE IMMUNITY; NEPAL; NORMAL HUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; SALMONELLA ENTERICA; SALMONELLA TYPHI; SCHOOL CHILD; TYPHOID FEVER;

EID: 70349670573     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00245-09     Document Type: Article

References (32)

1. Acharya, I. L., C. U. Lowe, R. Thapa, V. L. Gurubacharya, M. B. Shrestha, M. Cadoz, et al. 1987. Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report. N. Engl. J. Med. 317:1101-1104.
2. Bhan, M. K., R. Bahl, and S. Bhatnagar. 2005. Typhoid and paratyphoid fever. Lancet 366:749-762.
3. Brooks, W. A., A. Hossain, D. Goswami, K. Nahar, K. Alam, N. Ahmed, A. Naheed, G. B. Nair, S. Luby, and R. F. Breiman. 2005. Bacteremic typhoid fever in children in an urban slum, Bangladesh. Emerg. Infect. Dis. 11:326-329.
4. Chibber, S., and S. B. Bhardwaj. 2004. Protection in a mouse peritonitis model mediated by iron-regulated outer-membrane protein of Salmonella typhi coupled to its Vi antigen. J. Med. Microbiol. 53:705-709.
5. Crump, J. A., S. P. Luby, and E. D. Mintz. 2004. The global burden of typhoid fever. Bull. W. H. O. 82:346-353.
6. Crump, J. A., P. K. Ram, S. K. Gupta, M. A. Miller, and E. D. Mintz. 2008. Part I. Analysis of data gaps pertaining to Salmonella enterica serotype Typhi infections in low and medium human development index countries, 1984-2005. Epidemiol. Infect. 136:436-448.
7. Fothergill, L. D., and J. Wright. 1933. Influenzal meningitis: the relation of age incidence to the bactericidal power of blood against the causal organism. J. Immunol. 24:273-284.
8. Fraser, A., E. Goldberg, C. J. Acosta, M. Paul, and L. Leibovici. 2007. Vaccines for preventing typhoid fever. Cochrane Database Syst. Rev. 3:CD001261.
9. Fraser, A., M. Paul, E. Goldberg, C. J. Acosta, and L. Leibovici. 2007. Typhoid fever vaccines: systematic review and meta-analysis of randomised controlled trials. Vaccine 25:7848-7857. (Pubitemid 47588521)
10. Goldschneider, I., E. C. Gotschlich, and M. S. Artenstein. 1969. Human immunity to the meningococcus. I. The role of humoral antibodies. J. Exp. Med. 129:1307-1326.
11. Goldschneider, I., E. C. Gotschlich, and M. S. Artenstein. 1969. Human immunity to the meningococcus. II. Development of natural immunity. J. Exp. Med. 129:1327-1348.
12. Jumba, M. M., N. B. Mirza, and F. B. Mwaura. 1995. Salmonella typhi and Salmonella paratyphi antibodies in Kenya. East Afr. Med. J. 72:755-757.
13. Käyhty, H., H. Peltola, V. Karanko, and P. H. Mäkelä. 1983. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J. Infect. Dis. 147:1100.
14. Keitel, W. A., N. L. Bond, J. M. Zahradnik, T. A. Cramton, and J. B. Robbins. 1994. Clinical and serological responses following primary and booster immunization with Salmonella typhi Vi capsular polysaccharide vaccines. Vaccine 12:195-199.
15. Klugman, K. P., H. J. Koornhof, J. B. Robbins, and N. N. Le Cam. 1996. Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization. Vaccine 14:435-438.
16. Levine, M. M., C. O. Tacket, and M. B. Sztein. 2001. Host-Salmonella interaction: human trials. Microbes Infect. 3:1271-1279.
17. Lin, F. Y., V. A. Ho, H. B. Khiem, D. D. Trach, P. V. Bay, T. C. Thanh, Z. Kossaczka, D. A. Bryla, J. Shiloach, J. B. Robbins, R. Schneerson, and S. C. Szu. 2001. The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children. N. Engl. J. Med. 344:1263-1269.
18. Paliwal, P. K., A. Bansal, S. S. Sagi, S. Mustoori, and I. Govindaswamy. 2008. Cloning, expression and characterization of heat shock protein 60 (groEL) of Salmonella enterica serovar Typhi and its role in protective immunity against lethal Salmonella infection in mice. Clin. Immunol. 126:89-96.
19. Panchanathan, V., S. Kumar, W. Yeap, S. Devi, R. Ismail, S. Sarijan, S. M. Sam, Z. Jusoh, S. Nordin, D. Leboulleux, and T. Pang. 2001. Comparison of safety and immunogenicity of a Vi polysaccharide typhoid vaccine with a whole-cell killed vaccine in Malaysian Air Force recruits. Bull. W. H. O. 79:811-817.
20. Patil, A. M., M. L. Kulkarni, and A. M. Kulkarni. 2007. Baseline Widal titres in healthy children. Indian J. Pediatr. 74:1081-1083.
21. Pulickal, A. S., and A. J. Pollard. 2007. Vi polysaccharide-protein conjugate vaccine for the prevention of typhoid fever in children: hope or hype? Expert Rev. Vaccines 6:293-295.
22. Quataert, S. A., C. S. Kirch, L. J. Wiedl, D. C. Phipps, S. Strohmeyer, C. O. Cimino, J. Skuse, and D. V. Madore. 1995. Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S. Clin. Diagn. Lab. Immunol. 2:590-597.
23. Sagi, S. S., P. Paliwal, A. Bansal, C. Mishra, N. Khan, S. R. Mustoori, G. Ilavazhagan, R. C. Sawhney, and P. K. Banerjee. 2006. Studies on immunogenicity and protective efficacy of DnaJ of Salmonella Typhi against lethal infection by Salmonella Typhimurium in mice. Vaccine 24:7135-7141. (Pubitemid 46107198)
24. Saha, S. K., A. H. Baqui, M. Hanif, G. L. Darmstadt, M. Ruhulamin, T. Nagatake, M. Santosham, and R. E. Black. 2001. Typhoid fever in Bangladesh: implications for vaccination policy. Pediatr. Infect. Dis. J. 20:521-524.
25. Salazar-Gonzalez, R. M., C. Maldonado-Bernal, N. E. Ramirez-Cruz, N. Rios-Sarabia, J. Beltran-Nava, J. Castanon-Gonzalez, N. Castillo-Torres, J. A. Palma-Aguirre, M. Carrera-Camargo, C. Lopez-Macias, and A. Isibasi. 2004. Induction of cellular immune response and anti-Salmonella enterica serovar typhi bactericidal antibodies in healthy volunteers by immunization with a vaccine candidate against typhoid fever. Immunol. Lett. 93:115-122.
26. Sharma, N. P., S. J. Peacock, W. Phumratanaprapin, N. Day, N. White, and S. Pukrittayakamee. 2006. A hospital-based study of bloodstream infections in febrile patients in Dhulikhel Hospital Kathmandu University Teaching Hospital, Nepal. Southeast Asian J. Trop. Med. Public Health 37:351-356.
27. Sinha, A., S. Sazawal, R. Kumar, S. Sood, V. P. Reddaiah, B. Singh, M. Rao, A. Naficy, J. D. Clemens, and M. K. Bhan. 1999. Typhoid fever in children aged less than 5 years. Lancet 354:734-737. (Pubitemid 29405787)
28. Snape, M. D., D. F. Kelly, S. Lewis, C. Banner, L. Kibwana, C. E. Moore, L. Diggle, T. John, L. M. Yu, R. Borrow, A. Borkowski, C. Nau, and A. J. Pollard. 2008. Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational study. BMJ 336:1487-1491.
29. Tanyigna, K. B., J. A. Ayeni, E. N. Okeke, J. A. Onah, and C. S. Bello. 1999. Antibody levels to Salmonella typhi and paratyphi in Nigerians. East Afr. Med. J. 76:623-625.
30. Wahid, R., R. Salerno-Gonçalves, C. O. Tacket, M. M. Levine, and M. B. Sztein. 2007. Cell-mediated immune responses in humans after immunization with one or two doses of oral live attenuated typhoid vaccine CVD 909. Vaccine 25:1416-1425. (Pubitemid 46091821)
31. Wellcome Trust. 22 March 2005. Trust support for typhoid vaccine programme. Wellcome Trust, London, United Kingdom. http://www.wellcome.ac.uk/ News/Media-office/Press-releases/2005/WTX024429.htm.
32. Zailani, S. B., A. O. Aboderin, and A. O. Onipede. 2004. Effect of socioeconomic status, age and sex on antibody titre profile to Salmonella typhi/paratyphi in Ile-Ife, Nigeria. Niger. J. Med. 13:383-387.